Interclass difference in pneumonia risk in COPD patients initiating fixed dose inhaled treatment containing extrafine particle beclometasone versus fine particle fluticasone
Date
2022-02-15
Journal Title
Journal ISSN
Volume Title
Publisher
Citation
Price, D, Henley, W, Delfini Cançado, J E, Fabbri, L M, Kerstjens, H AM, Papi, A, Roche, N, Şen, E, Singh, D, Vogelmeier, C, Barille, S, Nudo, E, Carter, V, Skinner, D, Vella, R & Georges, G 2022, 'Interclass difference in pneumonia risk in COPD patients initiating fixed dose inhaled treatment containing extrafine particle beclometasone versus fine particle fluticasone', International journal of chronic obstructive pulmonary disease , vol. 2022, no. 17, pp. 355—370. https://doi.org/10.2147/COPD.S342357